Olcegepant
CAS No. 204697-65-4
Olcegepant ( BIBN-4096;BIBN-4096BS;BIBN4096BS )
Catalog No. M13181 CAS No. 204697-65-4
The first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 42 | Get Quote |
|
5MG | 87 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOlcegepant
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP.
-
DescriptionThe first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP; inhibits the effects of CGRP, released by stimulation of the trigeminal ganglion, on facial blood flow in marmoset monkeys (1-30mg/kg, i.v.).
-
SynonymsBIBN-4096;BIBN-4096BS;BIBN4096BS
-
PathwayGPCR/G Protein
-
TargetCGRP Receptor
-
RecptorCGRP Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number204697-65-4
-
Formula Weight869.65
-
Molecular FormulaC38H47Br2N9O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 50 mg/mL
-
SMILESO=C(N1CCC(N2C(NC3=C(C=CC=C3)C2)=O)CC1)N[C@H](CC4=CC(Br)=C(O)C(Br)=C4)C(N[C@H](C(N5CCN(C6=CC=NC=C6)CC5)=O)CCCCN)=O
-
Chemical NamePiperazine, 1-[3,5-dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Doods H, et al. Br J Pharmacol. 2000 Feb;129(3):420-3.
2. Powell KJ, et al. Br J Pharmacol. 2000 Nov;131(5):875-84.
3. Edvinsson L, et al. Eur J Pharmacol. 2002 Jan 2;434(1-2):49-53.
2. Powell KJ, et al. Br J Pharmacol. 2000 Nov;131(5):875-84.
3. Edvinsson L, et al. Eur J Pharmacol. 2002 Jan 2;434(1-2):49-53.
molnova catalog
related products
-
Ubrogepant
Ubrogepant (MK-1602) is a novel potent, selective, oral calcitonin gene-related peptide receptor (CGRP) antagonist for acute treatment of migraine.
-
Atogepant
A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine.
-
OTS514
OTS514 is a highly effective TOPK(T-LAK cell-originated protein kinase) inhibitor (IC50: 2.6 nM).